Ladenburg Thalmann Financial Services’s Invesco Pharmaceuticals ETF PJP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | $843K | Sell |
13,022
-1,006
| -7% | -$65.1K | 0.01% | 1404 |
|
2019
Q3 | $795K | Sell |
14,028
-554
| -4% | -$31.4K | 0.01% | 1399 |
|
2019
Q2 | $878K | Buy |
14,582
+3,402
| +30% | +$205K | 0.01% | 1316 |
|
2019
Q1 | $728K | Sell |
11,180
-700
| -6% | -$45.6K | 0.01% | 1406 |
|
2018
Q4 | $742K | Sell |
11,880
-41
| -0.3% | -$2.56K | 0.01% | 1244 |
|
2018
Q3 | $876K | Sell |
11,921
-1,406
| -11% | -$103K | 0.01% | 1211 |
|
2018
Q2 | $832K | Hold |
13,327
| – | – | 0.01% | 1181 |
|
2018
Q1 | $832K | Buy |
13,327
+440
| +3% | +$27.5K | 0.01% | 1181 |
|
2017
Q4 | $827K | Sell |
12,887
-473
| -4% | -$30.4K | 0.01% | 1191 |
|
2017
Q3 | $874K | Buy |
13,360
+2,429
| +22% | +$159K | 0.01% | 1076 |
|
2017
Q2 | $686K | Sell |
10,931
-1,916
| -15% | -$120K | 0.01% | 1184 |
|
2017
Q1 | $755K | Sell |
12,847
-6,540
| -34% | -$384K | 0.01% | 1051 |
|
2016
Q4 | $1.09M | Sell |
19,387
-2,877
| -13% | -$161K | 0.02% | 803 |
|
2016
Q3 | $1.37M | Buy |
22,264
+3,819
| +21% | +$236K | 0.02% | 634 |
|
2016
Q2 | $1.17M | Sell |
18,445
-283
| -2% | -$17.9K | 0.02% | 690 |
|
2016
Q1 | $1.13M | Sell |
18,728
-32,106
| -63% | -$1.93M | 0.02% | 647 |
|
2015
Q4 | $3.56M | Sell |
50,834
-1,630
| -3% | -$114K | 0.07% | 265 |
|
2015
Q3 | $3.48M | Buy |
52,464
+2,626
| +5% | +$174K | 0.07% | 264 |
|
2015
Q2 | $3.9M | Sell |
49,838
-1,184
| -2% | -$92.7K | 0.07% | 269 |
|
2015
Q1 | $3.9M | Buy |
51,022
+4,255
| +9% | +$325K | 0.07% | 266 |
|
2014
Q4 | $3.11M | Buy |
46,767
+35,067
| +300% | +$2.33M | 0.07% | 259 |
|
2014
Q3 | $744K | Sell |
11,700
-9,963
| -46% | -$634K | 0.02% | 624 |
|
2014
Q2 | $1.32M | Sell |
21,663
-10,450
| -33% | -$638K | 0.04% | 417 |
|
2014
Q1 | $1.82M | Sell |
32,113
-426
| -1% | -$24.1K | 0.05% | 288 |
|
2013
Q4 | $1.74M | Buy |
32,539
+20,974
| +181% | +$1.12M | 0.05% | 286 |
|
2013
Q3 | $492K | Buy |
11,565
+625
| +6% | +$26.6K | 0.02% | 671 |
|
2013
Q2 | $463K | Buy |
+10,940
| New | +$463K | 0.02% | 657 |
|